Skyline Ventures
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Their areas of expertise include small molecule and protein therapeutics; medical...Founded in 1997
Employees: 7
Homepage: http://www.skylineventures.com
Palo Alto Office
94301 525 University AvenueSuite 610
Palo Alto
USA CA
Phone: 650-462-5800
Skyline Ventures at CrunchBase
John J. Freund Managing Director
Yasunori Kaneko Managing Director
Stephen J. Hoffman Managing Director
Past
January, 2013
Skyline Ventures invested $28M in Crescendo Bioscience as a Series D round
October, 2012
Skyline Ventures invested $30M in Genocea Biosciences as a Series C round
May, 2012
Skyline Ventures invested $16.5M in Sutro Biopharma as a Series C round
February, 2012
Skyline Ventures invested $22.5M in Collegium Pharmaceutical as unattributed round
September, 2011
Skyline Ventures invested $16M in SI-BONE as unattributed round
January, 2011
Skyline Ventures invested $35M in Genocea Biosciences as a Series B round
November, 2010
Skyline Ventures invested $36.5M in Sutro Biopharma as a Series C round
August, 2010
Skyline Ventures invested $10.6M in SI-BONE as a Series B round
June, 2010
Skyline Ventures invested $45M in Tetraphase Pharmaceuticals as a Series C round
November, 2009
Skyline Ventures invested $1.4M in Calibra Medical as unattributed round
Skyline Ventures invested $50M in Calypso Medical as a Series E round
May, 2009
Skyline Ventures invested $50M in Proteon Therapeutics as a Series B round
February, 2009
Skyline Ventures invested $500K in SpinalMotion as a Series C round
August, 2008
Skyline Ventures invested $15M in Tetraphase Pharmaceuticals as a Series A round
Skyline Ventures invested $18.5M in InteKrin as a Series C round
May, 2008
Skyline Ventures invested $49.5M in NovaSys as unattributed round
April, 2008
Skyline Ventures invested $37M in Concert Pharmaceuticals as a Series C round
September, 2007
Skyline Ventures invested $12M in Proteon Therapeutics as a Series A round
July, 2007
Skyline Ventures invested $30M in Satiety as a Series D round
March, 2007
Skyline Ventures invested $50M in MAP Pharmaceuticals as a Series D round
November, 2006
Skyline Ventures invested $48.5M in Concert Pharmaceuticals as a Series B round
July, 2006
Skyline Ventures invested $10M in Concert Pharmaceuticals as a Series A round
May, 2006
Skyline Ventures invested $43.8M in Avidia as a Series C round
Skyline Ventures invested $35M in KAI Pharmaceuticals as a Series B round
December, 2004
Skyline Ventures invested $13M in Sirtris Pharmaceuticals as a Series A round
November, 2003
Skyline Ventures invested $27M in Applied Genetics Technologies Corporation as a Series B round
1997
Skyline Ventures was founded in 1997